Health Longevity Secrets Podcast Por Robert Lufkin MD arte de portada

Health Longevity Secrets

Health Longevity Secrets

De: Robert Lufkin MD
Escúchala gratis

La oferta más grande de la temporada | US$0.99/mes por 3 meses + US$20 de vale en Audible

US$8.99 al mes después de 3 meses. Consulta términos y condiciones.
Acerca de esta escucha

The health advice you're getting isn't working. Want to know what the experts actually do for themselves?

Health Longevity Secrets reveals the real science behind longevity, metabolic health, fasting, and disease reversal—the protocols that researchers and physicians use in their own lives, not just what they tell patients.

Robert Lufkin MD is a medical school professor, practicing physician, and New York Times bestselling author. After reversing his own chronic disease through lifestyle medicine, he's on a mission to share what actually works.

Each episode features in-depth interviews with world-class scientists, doctors, and biohackers who share their personal health strategies—no sponsored talking points, just real answers.

Your health transformation starts here.

© 2026 Health Longevity Secrets
Ciencia Higiene y Vida Saludable Política y Gobierno
Episodios
  • Heart Attacks Are Becoming Optional (Here's the Proof)
    Nov 17 2026
    Most first heart attacks aren't bad luck: about 90% of risk is linked to measurable, changeable factors.I'm Dr. Robert Lufkin. I cover heart-risk measures, CAC scanning, semaglutide, and CHIP.KEY TAKEAWAYSINTERHEART found that nine risk factors explained about 90% of the risk of a first heart attack in men and about 94% in women, across 52 countries.The five numbers to hit: ApoB or LDL, blood pressure, blood sugar and insulin resistance, not smoking, and Lp(a). Most people have never had ApoB or Lp(a) checked.The 2026 U.S. cholesterol guideline restores LDL targets: under 100 for borderline/intermediate risk, under 70 for high risk, and under 55 for very-high risk with prior heart disease.Measure Lp(a) once in adulthood. At 125 nmol/L (about 50 mg/dL), long-term risk is about 1.4 times higher. At 250 nmol/L or more, it's at least double.In MESA, a calcium score of zero almost always meant a 10-year risk under 5%. A score of 100 or more meant over 7.5% in every group studied. A score of zero is reassuring, not a lifetime pass.Coronary artery calcium (CAC) scanning is available across the U.S. through: Innerscopic.com (I'm affiliated with Innerscopic.)In SELECT, weekly semaglutide cut combined heart attacks, strokes, and heart deaths by 20% in people with heart disease, overweight or obesity, and no diabetes; heart death alone was not statistically significant.CHIP was linked to about 1.9 times the risk of coronary heart disease, and about 4 times the risk in people who had heart attacks young. A 2026 Nature paper found lifestyle effects that depend on the mutation. Routine CHIP testing is not yet standard care."Optional" means most of the risk is in your control. It does not mean your risk goes to zero.STUDIES & SOURCESINTERHEART (Yusuf et al., The Lancet 2004) Read studyApoB particles and heart risk (Ference et al., JAMA 2019) Read study2026 ACC/AHA Multisociety Dyslipidemia Guideline (JACC) Read sourceACC/AHA 2026 guideline press summary Read source2025 AHA/ACC High Blood Pressure Guideline Read sourceMESA calcium score and 10-year risk (Budoff et al., European Heart Journal 2018) Read sourceSELECT trial (Lincoff et al., NEJM 2023) Read sourceCHIP and heart disease (Jaiswal et al., NEJM 2017) Read sourceSleep, exercise, and blood clones (Gerhardt et al., Nature 2026) Read sourceWatch the videoNewsletterBook: Lies I Taught in Medical SchoolWebsiteThis episode is for education only and is not medical advice. Don't start or stop any drug because of a podcast. Talk with your own physician before you change any medication, supplement, or routine.⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/
    Más Menos
    8 m
  • Alzheimer's Fraud Exposed | Charles Piller
    Nov 10 2026
    Alzheimer's research fraud: what happens when influential studies cannot be trusted? In this episode of Health Longevity Secrets, Robert Lufkin MD speaks with investigative journalist Charles Piller about research integrity, the amyloid hypothesis, and the human cost of unreliable science. We discuss Matthew Schrag's image analysis, the retracted 2006 Nature paper, simufilam, and why patients need both rigorous research and better care.Chapters:00:00 — Introduction01:40 — Charles Piller and the Origins of Doctored07:16 — Alzheimer's Disease and the Amyloid Hypothesis11:40 — Amyloid Research, Funding, and Scientific Gatekeeping14:49 — The Retracted Nature Paper and Amyloid-Beta Star 5619:55 — Simufilam, Cassava Sciences, and Patient Opportunity Costs24:07 — Stroke Research and the Berislav Zlokovic Investigation27:10 — How Scientists Detect Manipulated Research Images30:40 — Research Misconduct Beyond Alzheimer's Disease33:14 — Exploring Infection, Inflammation, and GLP-1 Research35:56 — Brain Health: Prevention and Care Alongside Cure37:40 — Publish or Perish: Changing Scientific Incentives41:22 — NIH, FDA, and Accountability in Science44:07 — Responses to Doctored and Scientific Criticism46:26 — Reasons for Hope, Guest Resources, and ClosingKEY TAKEAWAYS:A retracted paper must not be treated as reliable supporting evidence.Piller argues that research incentives can discourage challenges to established ideas.Failed trials can carry substantial opportunity costs for patients and families.Scientific skepticism should lead to stronger evidence, not blanket distrust.Care and prevention deserve attention alongside the search for treatments.IMPORTANT CONTEXT:The episode presents Piller's reporting and interpretations; allegations are not the same as established findings. The 2006 Nature paper was retracted in 2024. That retraction does not by itself disprove every role for amyloid in Alzheimer's disease. Some anti-amyloid treatments slow decline in selected patients; slowing decline is not stopping or reversing the disease, and treatment carries risks.STUDIES & SOURCES DISCUSSED:Charles Piller / Doctored: https://charlespiller.com/Piller's Science investigation, "Blots on a field?": https://www.science.org/content/article/potential-fabrication-research-images-threatens-key-theory-alzheimers-diseaseLesne et al., Nature 2006 (RETRACTED): https://pubmed.ncbi.nlm.nih.gov/16541076/Nature's 2024 retraction notice: https://www.nature.com/articles/s41586-024-07691-8Science reporting on Zlokovic and the stroke trial: https://www.science.org/content/article/top-alzheimer-s-researcher-goes-leave-amid-misconduct-concernsADDITIONAL CONTEXT:Published phase 3 simufilam results: https://pmc.ncbi.nlm.nih.gov/articles/PMC12988371/FDA Leqembi prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761269s011lbl.pdfSubscribe for more evidence-based health conversations.Robert Lufkin MD's book, Lies I Taught in Medical School: https://robertlufkinmd.com/lies/Newsletter: https://robertlufkinmd.substack.comWebsite: https://robertlufkinmd.com#Alzheimers #MetabolicHealth #HealthLongevitySecrets⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/
    Más Menos
    51 m
  • Are Peptides Legal Now? What Actually Changed
    Nov 3 2026

    On October 28, 2026, HHS said it will allow pharmacies to compound six popular peptides: BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon. Not one of them is FDA approved, and the Associated Press reported that FDA scientists opposed the change. In this episode, Robert Lufkin MD explains what the policy actually allows, the conditions pharmacies have to meet, and what the human evidence shows for each of the six peptides. He also covers the risks and three questions to ask before considering any compounded peptide.

    In this episode:
    (00:00) Six peptides get a green light
    (00:45) What actually changed
    (02:08) The fine print
    (02:58) BPC-157 and TB-500
    (04:08) KPV, Semax, and Epitalon
    (05:02) MOTS-c and the metabolic root
    (05:53) The honest caveat
    (07:02) The takeaway

    Watch the video: https://youtu.be/kX8PD65-hZo

    Key sources:
    - BakerHostetler policy summary: https://www.bakerlaw.com/insights/hhs-issues-enforcement-discretion-policy-regarding-503a-compounding-using-certain-peptide-bulk-drug-substances/

    - AP News: https://apnews.com/article/peptides-fda-rfk-compounding-8da016068c004486159514d3a7471fd7
    - Poolton JT et al., Acta Orthop Belg 2026: https://doi.org/10.52628/92.3.15837
    - Ruff D et al., Ann N Y Acad Sci 2010: https://doi.org/10.1111/j.1749-6632.2010.05474.x
    - Al-Dulaimi S et al., Biogerontology 2025: https://doi.org/10.1007/s10522-025-10315-x
    - Lee C et al., Cell Metab 2015: https://doi.org/10.1016/j.cmet.2015.02.009
    Full source list in the YouTube description.

    Educational content only, not medical advice.
    Robert Lufkin MD | https://www.robertlufkinmd.com

    ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!

    New episodes every other Tuesday. Subscribe so you don't miss one.

    Continue this conversation on Substack: https://robertlufkinmd.substack.com


    Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/

    Web: https://www.robertlufkinmd.com
    YouTube: https://www.youtube.com/robertlufkinmd
    X: https://x.com/robertlufkinmd
    Instagram: https://www.instagram.com/robertlufkinmd/
    TikTok: https://www.tiktok.com/@robertlufkin
    LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

    Más Menos
    8 m
adbl_web_anon_alc_button_suppression_t1
Todavía no hay opiniones
adbl_web_global_use_to_activate_webcro_2487_promo_pdp_banner_buybox_T2_holiday_sweetener